Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Disc Medicine, Inc.

Disc Medicine, Inc. (IRON) Stock Overview

Explore Disc Medicine, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IRON●NASDAQ
HealthcareBiotechnology
$74.12
$1.74(2.29%)
U.S. Market opens in 2h 23m

Disc Medicine, Inc. (IRON)

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio-11.15
EPS (TTM)$-6.62
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$73.94
3 Months$93.52
1 Year Target$87.18

IRON Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Disc Medicine, Inc. (NASDAQ: IRON) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Disc Medicine, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IRON on the NASDAQ shows an RSI of 50.18, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $87.18 for the NASDAQ listing.

Key metrics behind Disc Medicine, Inc.'s NASDAQ-traded stock include a P/E ratio of -11.15 and a market capitalization of 2.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IRON on the NASDAQ.

Price Performance (NASDAQ: IRON)

1-Day Change
-2.29%
5-Day Change
2.04%
1-Month Change
5.33%
3-Month Change
7.65%
6-Month Change
-2.90%
Year-to-Date (YTD) Change
-6.66%
1-Year Change
22.35%
3-Year Change
62.51%
5-Year Change
62.90%
All-Time (Max) Change
-28.04%

Contact Information

https://www.discmedicine.com
617 674 9274
321 Arsenal Street, Watertown, MA, 02472

Company Facts

1,550 Employees
IPO DateAug 12, 2020
CountryUS
Actively Trading

Frequently Asked Questions